Clinical Trial

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) detection in a surveillance population.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2021-09-30; most recent amendment 2025-10-13.
Status change: Recruiting → Active, Not Recruiting 2025-10-13
Status change: Active, Not Recruiting → Recruiting 2023-08-01
Status change: Recruiting → Active, Not Recruiting 2023-04-19
Trial Details
NCT Number NCT05064553
Lead Sponsor Exact Sciences Corporation
Conditions Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
Enrollment 2,990 participants
Start Date 2021-07-26
Primary Completion 2025-09-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-15